<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>131(2)</volume><submitter>Kendrick J</submitter><funding>Department of Health, Government of Western Australia</funding><pubmed_abstract>&lt;h4>Objectives&lt;/h4>The primary aim of this study was to quantify the subject-level test-retest repeatability of artificial intelligence (AI)-derived PSMA PET imaging biomarkers using a previously developed model. The secondary aim was to assess the performance of this segmentation model, which was trained on [&lt;sup>68&lt;/sup> Ga]Ga-PSMA-11 PET scans, on [&lt;sup>18&lt;/sup>F]F-PSMA-1007 PET scans.&lt;h4>Methods&lt;/h4>This was a post-hoc analysis of a prospective, single-center, test-retest trial. Seventeen patients with metastatic prostate cancer (mPCa) were randomised into groups, either receiving the same tracer ([&lt;sup>68&lt;/sup> Ga]Ga-PSMA-11 or [&lt;sup>18&lt;/sup>F]F-PSMA-1007) for both scans (intra-tracer group, n = 9) or a different tracer (inter-tracer group, n = 8). Scans were delineated using a fully </pubmed_abstract><journal>La Radiologia medica</journal><pagination>320-331</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12932408</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Deep learning-based PSMA PET segmentation repeatability: A post-hoc analysis of a single-center, prospective, test-retest trial.</pubmed_title><pmcid>PMC12932408</pmcid><pubmed_authors>Ebert MA</pubmed_authors><pubmed_authors>Hassan GM</pubmed_authors><pubmed_authors>Barry N</pubmed_authors><pubmed_authors>Ong JSL</pubmed_authors><pubmed_authors>Jeraj R</pubmed_authors><pubmed_authors>Kendrick J</pubmed_authors><pubmed_authors>Francis RJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Deep learning-based PSMA PET segmentation repeatability: A post-hoc analysis of a single-center, prospective, test-retest trial.</name><description>&lt;h4>Objectives&lt;/h4>The primary aim of this study was to quantify the subject-level test-retest repeatability of artificial intelligence (AI)-derived PSMA PET imaging biomarkers using a previously developed model. The secondary aim was to assess the performance of this segmentation model, which was trained on [&lt;sup>68&lt;/sup> Ga]Ga-PSMA-11 PET scans, on [&lt;sup>18&lt;/sup>F]F-PSMA-1007 PET scans.&lt;h4>Methods&lt;/h4>This was a post-hoc analysis of a prospective, single-center, test-retest trial. Seventeen patients with metastatic prostate cancer (mPCa) were randomised into groups, either receiving the same tracer ([&lt;sup>68&lt;/sup> Ga]Ga-PSMA-11 or [&lt;sup>18&lt;/sup>F]F-PSMA-1007) for both scans (intra-tracer group, n = 9) or a different tracer (inter-tracer group, n = 8). Scans were delineated using a fully </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T21:32:44.165Z</modification><creation>2026-07-10T03:16:28.009Z</creation></dates><accession>S-EPMC12932408</accession><cross_references><pubmed>41166032</pubmed><doi>10.1007/s11547-025-02137-1</doi></cross_references></HashMap>